FGD Market for new FGD Systems (Wet and
Dry FGD systems), Reagents and Replacement Applications - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2019
Power
plants utilizing fossil fuel such as coal emit sulfur dioxide with the flue
gas, cause harmful environmental effects such as acid rain. To remove sulfur
dioxide from the flue gas, flue gas desulfurization (FGD) systems are
extensively used and with the introduction of new stringent government policies
and regulations, companies are going for FGD systems to reduce harmful gaseous
substances such as SO2 emission.
This
research study analyzes the market size of FGD, in terms of revenue. The FGD
market has been segmented on the basis of technology, application, and
geography, in order to provide a holistic picture of the market. Market data
for all segments has been provided on a regional level for the period 2012 to
2019. A comprehensive competitive landscape including company market share
analysis has also been provided in this report.
To check out the complete table of
contents, visit: http://www.marketresearchreports.biz/analysis-details/flue-gas-desulfurization-systems-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Key
technologies analyzed in the report include wet and dry FGD systems. FGD
application market segments estimated in this study include new FGD systems,
reagents (lime, limestone and sea water) and replacement market (FGD equipment
and components). Regional data has been provided for North America, Europe,
Asia Pacific, and Rest of the World (RoW). It also provides detailed analysis,
historical data, and statistically refined forecast for the segments
covered.
This
report also includes Porter’s five forces model analysis, value chain analysis,
and market attractiveness analysis by technology. Some of the key market
participants that deal in FGD market include Alstom, Siemens Energy, Babcock
& Wilcox, Hamon RC, Thermax, Ducon Technologies, Mitsubishi Heavy
Industries (MHI), and Marsulex Environmental Technologies (MET). The report
provides an overview of these companies followed by their financial revenue,
business strategies, and recent developments.
The
research provides detailed analysis of companies dealing FGD, trend analysis
and demand forecast by geography. The study presents a comprehensive assessment
of the stakeholder strategies, winning imperatives for them by segmenting the
FGD market as below:
Flue
Gas Desulfurization Market: Application Analysis
- New Flue Gas Desulfurization Systems
- Reagents and Replacement market
New
Flue Gas Desulfurization Systems Market: Technology Analysis
- Wet FGD systems
- Dry FGD systems
Flue
Gas Desulfurization Market: Regional Analysis
- North America
- Europe
- Asia-Pacific
- Rest of the World (Middle East, Africa and Brazil)
Latest Reports:
Apoptosis
Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019: http://www.marketresearchreports.biz/analysis-details/apoptosis-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Apoptosis
is a programmed natural process of cell death in the body which results from
natural stimuli in order to protect against viral infection, unusual cell
division and cells with damaged genetic material. However malfunctioning of
apoptosis can trigger uncontrolled and non regulated cell death related to
degenerative disorders such as Parkinson’s disease and Alzheimer’s. Defective
apoptosis process has been one of the most common and leading causes for cancer
wherein the affected cells instead of undergoing apoptosis continue to
proliferate and mutate. Thus development of apoptosis modulating drugs has
recently been witnessing spectacular growth in the treatment for cancer, CNS
diseases, and chronic inflammation or autoimmunity disorders.
The
global apoptosis market is categorized by:
Drug
class and consumables
- Direct apoptogens
- First generation indirect apoptogens
- Second generation indirect apoptogens
- Reagents and kits
Indications
- Cancer
- Cardiovascular
- Neurodegenerative diseases
Currently,
North America dominates the global apoptosis market and is followed by Europe
due to existence of huge potential for apoptosis modulating therapeutics and
rising popularity of targeted cancer therapy. Emerging economies of
Asia-Pacific, Latin America, Middle East and Africa are also expected to
undergo rapid growth in the apoptosis market due to the rising incidences of
cancer and unmet treatment needs in such developing regions.
Biological Drugs Market - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019: http://www.marketresearchreports.biz/analysis-details/biological-drugs-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Biological
drugs are biological medical products whose active drug substance is extracted
by using living organism. The active substance is derived from living organism
by the usage of recombinant DNA technology. These drugs offer better treatment
solutions than synthetic drugs owing to greater accuracy and fewer side
effects. Biological drugs are mainly made of monoclonal antibodies (mAbs) that
help to fight with the disease. Monoclonal antibodies have the capability of
targeting specific area in the body that requires drug treatment hence
producing accurate results. Majorly biologic drugs are given for the treatment
of diseases such as HIV/AIDS, Alzheimer’s diseases, cancers and others.
Moreover, biologic drugs are also expected to find a solution for the large
portion of retired population which is more prone to chronic diseases.
Global
biological drugs market is growing at substantial rate owing to the drug
accuracy and increase in chronic diseases. In addition, biologic drugs have
shown a better outcome in long term and offer a better quality of life. There
are approximately 150 biologic drugs commercially available in the markets
which are being used to treat diseases such as asthma, irritable bowel
syndrome, rheumatoid arthritis, cancer and others. For example, Avastin for the
treatment of lung cancer and Cerezyme for Gaucher disease are commercially
available and cost about USD 100,000 and USD 300,000 per year respectively.
However, half of the biological drugs are about to lose their patent protection
and as a result cheaper alternative biogeneric products are expected to enter
in to the market. On the contrary, cost of the biologic drugs is one the major
restraining factor for the growth of this market. Biologic drugs are costly as
compared to other drugs but are likely to become cheaper in near future. Owing
to the potential benefits of the biologic drugs they have been put on fast
track FDA approval process.
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This
report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
About Us
MarketResearchReports.Biz is the most comprehensive
collection of market research reports. MarketResearchReports.Biz services are specially
designed to save time and money for our clients. We are a one stop solution for
all your research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve all
sizes and types of companies spanning across various industries.
Contact
M/s
Sheela
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA
– Canada Toll Free: 866-997-4948
Blog:
http://industry-research-reports.blogspot.com/
